Design Therapeutics, Inc.DSGNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-43.45M
↓ 34% below average
Average (5y)
$-32.38M
Historical baseline
Range
High:$-139000.00
Low:$-58.82M
CAGR
+215.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-43.45M | +26.1% |
| 2023 | $-58.82M | -12.6% |
| 2022 | $-52.23M | -69.0% |
| 2021 | $-30.91M | -253.5% |
| 2020 | $-8.74M | -6191.4% |
| 2019 | $-139000.00 | - |